Can’t see the audio player? Click here to listen.
Click here for a transcript of the episode.
Can a healthcare company make enough people mad about its billing practices that it hurts its business? For a genetic testing company, maybe.
An “Arm and a Leg” listener received a test that has become routine early in pregnancy: the noninvasive prenatal test. It was supposed to be $99. But then – after he took the test – that turned out to be $250. And when she asked questions, she was told it could go up to $800 if she didn’t pay quickly. The patient looked at testing companies and found that many people had experienced what he called the “genetic testing bait-and-switch.”
And importantly – he’s not the only one who noticed. When some people on Wall Street, and a New York Times reporter, started hearing about those bills, the company found itself in hot water.
“An Arm and a Leg” is a co-production of KHN and Public Road Productions.
To stay in touch with “An Arm and a Leg”, subscribe to the newsletter. You can also follow the show on Facebook and Twitter. And if you have a story to tell about the health care system, producers would love to hear from you.
To listen to all KHN podcasts, click here.
And subscribe to “An Arm and a Leg” on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts.
We encourage companies to republish our content free of charge. Here’s what we ask:
You must credit us as the original publisher with a hyperlink to our khn.org site. If possible, please include the original author(s) and “Kaiser Health News” in the byline. Save the hyperlink in the story.
It’s important to note, not everything on khn.org is available for republishing. If a story is labeled “All Rights Reserved,” we may not allow that item to be republished.
Have questions? Let us know at [email protected]